Home » Topics » Regulatory » EMA

EMA
RSS

EMA accepts olaparib MAA for review

Sep. 30, 2013

EMA committee recommends approval of Cimzia in new indication

Sep. 25, 2013

CHMP issues positive opinion for PSD-502 in premature ejaculation

Sep. 25, 2013

Kineret receives positive CHMP opinion for cryopyrin-associated periodic syndromes

Sep. 25, 2013

EMA committee recommends approval of Xofigo injection for CRPC

Sep. 23, 2013

Trastuzumab emtansine receives committee recommendation in E.U.

Sep. 23, 2013

CHMP recommends E.U. approval of canagliflozin

Sep. 23, 2013

Novo Nordisk's NovoEight gets positive opinion in E.U.

Sep. 23, 2013

Otsuka and Lundbeck receive positive CHMP opinion for Abilify Maintena

Sep. 23, 2013

EMA committee issues positive opinion on AstraZeneca's four-strain flu vaccine

Sep. 23, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...